EUVIMEDEUVIMED entdecken
Crossref

Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation

T Álvaro Thomsen, J Mesa Guadalupe iD, C Huerta iD, A de Burgos iD, L Cea Soriano

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.5733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von T Álvaro Thomsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Maternal Child Health, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Stroke, Atrial Fibrillation, Ischemic Stroke. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although direct oral anticoagulants' (DOACs) prescriptions have experienced immense growth in the last decade, the proportion of discontinuers is still common yielding an increased risk of ischemic stroke (IS) onset.

Aims

We aimed to estimate the association between DOACs discontinuation and risk of IS among patients with non‐valvular atrial fibrillation (NVAF).

Methods

We used data from a cohort of new DOACs users, followed patients from the first DOAC prescription date up to IS (index date) and conducted a nested case–control analysis using conditional logistic regression. Adjusted odds ratios, 95% confidence intervals were calculated for discontinuation of DOACs (current use compared with past use). The latter, subdivided among those stopping treatment 3 to 2 months and 6 and 3 months prior to index date. The effect of naïve current users against IS onset compared with non‐naïve current users was also evaluated.

Results

DOACs discontinuation showed an OR of IS of 1.47 (95% CI: 1.02–2.12); estimates were 2.51 (95% CI: 1.84–3.42) for whom discontinued treatment within months 3 and 2 and 1.43 (95% CI: 0.96–2.13) for those between months 6 and 3 prior to index date. Analyzing DOACs individually, risk of IS associated with past users compared with current users: 1.98 (95% CI: 1.25–3.12) for apixaban, 1.38 (95% CI: 0.40–4.72) for edoxaban, 1.98 (95% CI: 1.24–2.65) for dabigatran and 1.87 (95% CI: 1.26–2.76) for rivaroxaban. Similar results were found when stratified by naïve and non‐naïve users.

Conclusions

DOACs' discontinuation is associated with higher risk of IS, especially in the second and third months following interruption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeAtrial FibrillationIschemic StrokeHumansAnticoagulantsHemorrhageRivaroxabanDabigatranPyridonesAdministration, OralRetrospective Studies

Stichwörter der Autor:innen

DOACsanticoagulantsatrial fibrillationcohort studyischemic strokestroke

Substanzen

AnticoagulantsRivaroxabanDabigatranPyridones

Autor:innen und Institutionen

  • Department of Public Health and Maternal Child Health, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain.
  • BIFAP, Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.

ORCID-Profile: J Mesa Guadalupe, C Huerta, A de Burgos

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Álvaro Thomsen, T., Mesa Guadalupe, J., Huerta, C., de Burgos, A., & Cea Soriano, L. (2024). Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5733

Vancouver

Álvaro Thomsen T, Mesa Guadalupe J, Huerta C, de Burgos A, Cea Soriano L. Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5733

BibTeX
@article{lvaroThomsen2024,
  author = {Álvaro Thomsen, T and Mesa Guadalupe, J and Huerta, C and de Burgos, A and Cea Soriano, L},
  title = {Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.5733}
}
Kostenlos starten →